// App-Quantinova.ai

: Late Breaking Abstract - Effectiveness and safety of mepolizumab in real-world clinical practice: the REALITI-A study

Researchers

Presenter

  • Tim Harrison

Principal Investigators

  • G.Walter Canonica

  • Kim Gemzoe

  • Aoife Maxwell

  • Shibing Yang

  • Sandra Joksaite

  • Ronan OReilly

  • Melissa Van Dyke

  • Frank C. Albers

  • Namhee Kwon

Medical Centers

  • Nottingham NIHR Biomedical Research Centre, Nottingham City Hospital, University of Nottingham, Nottingham, United Kingdom

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy

  • Real World Study Delivery, Value Evidence and Outcomes, Global Medical, GSK, Uxbridge, United Kingdom

  • Real World Study Delivery, Value Evidence and Outcomes, Global Medical, GSK, Uxbridge, United Kingdom

  • Value Evidence & Outcomes, GSK, Collegeville, PA, United States,

  • Clinical Statistics, R&D Projects Clinical Platforms and Sciences, GSK, Uxbridge, United Kingdom

  • Epidemiology, Upper Providence, United States of America

  • Respiratory Medical Franchise, GSK, Research Triangle Park, NC, United States,

  • Respiratory Medical Franchise, GSK, GSK House, Brentford, United States of America

Locations

  • United Kingdom

  • Italy

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • Observational

  • Single Arm

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved